The HPV vaccine Gardasil 9 (HPV 9-valent Vaccine, Recombinant) is now approved by the FDA for use in males and females aged 9 through 45 years.1
The company also noted that “Gardasil 9 is contraindicated in individuals with hypersensitivity, including severe allergic reactions to yeast, or after a previous dose of Gardasil 9 or Gardasil."
- FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. FDA. Published October 5, 2018. Accessed October 7, 2018. https://bit.ly/2zVRxa9.
- FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for GARDASIL®9 in Women and Men Ages 27 to 45 for the Prevention of Certain HPV-Related Cancers and Diseases. Merck. Published June 13, 2018. Accessed October 7, 2018. https://bit.ly/2zWvlgo.
... to read the full story